Vault-13

Bellevue Group AG

ZURICH, V8 · CIK 1674546 · 13F filing filed 2024-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

Other 13F filers in this group: Bellevue Asset Management AG files a notice

$6.2bn reported value -6.1% vs Q1 2024
166positions
40.0%in top 10
10 new 63 added 61 reduced 13 sold out vs Q1 2024

This report includes the holdings of 3 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 IONIS PHARMACEUTICALS INC COM IONS IONS 8,260,434 $393.7m6.40% 6.40% ReducedShares held: Q3 2023 9.2m, Q4 2023 8.7m, Q1 2024 8.3m, Q2 2024 8.3m -39.1k -39,080 -0.5%
2 ARGENX SE SPONSORED ADR ARGX ARGX 691,874 $297.5m4.83% 4.83% ReducedShares held: Q3 2023 911.5k, Q4 2023 869.2k, Q1 2024 811.0k, Q2 2024 691.9k -119.1k -119,142 -14.7%
3 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 593,461 $278.2m4.52% 4.52% ReducedShares held: Q3 2023 1.0m, Q4 2023 736.4k, Q1 2024 668.8k, Q2 2024 593.5k -75.3k -75,289 -11.3%
4 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 1,898,640 $261.4m4.25% 4.25% ReducedShares held: Q3 2023 2.6m, Q4 2023 2.4m, Q1 2024 2.1m, Q2 2024 1.9m -157.2k -157,234 -7.7%
5 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 539,904 $240.2m3.90% 3.90% ReducedShares held: Q3 2023 829.0k, Q4 2023 832.0k, Q1 2024 682.2k, Q2 2024 539.9k -142.3k -142,282 -20.9%
6 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 919,834 $223.5m3.63% 3.63% AddedShares held: Q3 2023 894.3k, Q4 2023 885.3k, Q1 2024 918.3k, Q2 2024 919.8k +1.6k +1,550 0.2%
7 BOSTON SCIENTIFIC CORP COM BSX BSX 2,569,588 $197.9m3.22% 3.22% ReducedShares held: Q3 2023 2.6m, Q4 2023 3.2m, Q1 2024 3.1m, Q2 2024 2.6m -579.1k -579,088 -18.4%
8 REVOLUTION MEDICINES INC COM RVMD RVMD 5,029,100 $195.2m3.17% 3.17% ReducedShares held: Q3 2023 4.7m, Q4 2023 5.1m, Q1 2024 5.1m, Q2 2024 5.0m -44.5k -44,500 -0.9%
9 STRYKER CORPORATION COM SYK SYK 545,934 $185.8m3.02% 3.02% AddedShares held: Q3 2023 475.6k, Q4 2023 465.7k, Q1 2024 449.3k, Q2 2024 545.9k +96.6k +96,594 21.5%
10 MODERNA INC COM MRNA MRNA 1,563,735 $185.7m3.02% 3.02% ReducedShares held: Q3 2023 1.5m, Q4 2023 1.9m, Q1 2024 1.7m, Q2 2024 1.6m -147.4k -147,354 -8.6%
11 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 2,471,285 $169.3m2.75% 2.75% ReducedShares held: Q3 2023 3.2m, Q4 2023 3.1m, Q1 2024 2.8m, Q2 2024 2.5m -348.2k -348,197 -12.3%
12 AGIOS PHARMACEUTICALS INC COM AGIO AGIO 3,879,548 $167.3m2.72% 2.72% ReducedShares held: Q3 2023 4.0m, Q4 2023 4.0m, Q1 2024 4.0m, Q2 2024 3.9m -126.5k -126,452 -3.2%
13 ABBOTT LABS COM ABT ABT 1,606,153 $166.9m2.71% 2.71% AddedShares held: Q3 2023 1.6m, Q4 2023 1.5m, Q1 2024 1.4m, Q2 2024 1.6m +172.0k +171,970 12.0%
14 DEXCOM INC COM DXCM DXCM 1,268,687 $143.8m2.34% 2.34% AddedShares held: Q3 2023 685.7k, Q4 2023 914.6k, Q1 2024 1.2m, Q2 2024 1.3m +47.5k +47,490 3.9%
15 INCYTE CORP COM INCY INCY 2,153,504 $130.5m2.12% 2.12% AddedShares held: Q3 2023 2.5m, Q4 2023 2.2m, Q1 2024 2.2m, Q2 2024 2.2m +116 +116 0.0%
16 EDWARDS LIFESCIENCES CORP COM EW EW 1,260,461 $116.4m1.89% 1.89% AddedShares held: Q3 2023 1.0m, Q4 2023 1.0m, Q1 2024 1.1m, Q2 2024 1.3m +157.3k +157,325 14.3%
17 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 2,971,615 $110.0m1.79% 1.79% AddedShares held: Q3 2023 1.9m, Q4 2023 2.4m, Q1 2024 2.8m, Q2 2024 3.0m +175.0k +175,000 6.3%
18 UNITEDHEALTH GROUP INC COM UNH UNH 205,675 $104.7m1.70% 1.70% AddedShares held: Q3 2023 258.2k, Q4 2023 138.2k, Q1 2024 148.7k, Q2 2024 205.7k +57.0k +56,956 38.3%
19 INSULET CORP COM PODD PODD 435,420 $87.9m1.43% 1.43% AddedShares held: Q3 2023 264.4k, Q4 2023 289.9k, Q1 2024 293.8k, Q2 2024 435.4k +141.6k +141,592 48.2%
20 BECTON DICKINSON & CO COM BDX BDX 347,333 $81.2m1.32% 1.32% ReducedShares held: Q3 2023 304.2k, Q4 2023 388.1k, Q1 2024 415.7k, Q2 2024 347.3k -68.4k -68,367 -16.4%
21 MEDTRONIC PLC SHS MDT MDT 1,001,747 $78.8m1.28% 1.28% ReducedShares held: Q3 2023 641.5k, Q4 2023 970.8k, Q1 2024 1.0m, Q2 2024 1.0m -5.3k -5,253 -0.5%
22 BIOHAVEN LTD COM BHVN BHVN 2,040,853 $70.8m1.15% 1.15% AddedShares held: Q3 2023 0, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 2.0m +890.9k +890,853 77.5%
23 INSMED INC COM PAR $.01 INSM INSM 1,021,700 $68.5m1.11% 1.11% ReducedShares held: Q3 2023 3.2m, Q4 2023 2.3m, Q1 2024 2.1m, Q2 2024 1.0m -1.1m -1,120,143 -52.3%
24 ARVINAS INC COM ARVN ARVN 2,390,800 $63.6m1.03% 1.03% UnchangedShares held: Q3 2023 2.1m, Q4 2023 2.5m, Q1 2024 2.4m, Q2 2024 2.4m
25 TANDEM DIABETES CARE INC COM NEW TNDM TNDM 1,543,267 $62.2m1.01% 1.01% ReducedShares held: Q3 2023 2.1m, Q4 2023 2.0m, Q1 2024 2.0m, Q2 2024 1.5m -488.6k -488,621 -24.1%
26 CAREDX INC COM CDNA CDNA 3,912,575 $60.8m0.99% 0.99% ReducedShares held: Q3 2023 3.9m, Q4 2023 4.0m, Q1 2024 3.9m, Q2 2024 3.9m -21.4k -21,431 -0.5%
27 ELEVANCE HEALTH INC COM ELV ELV 101,549 $55.0m0.89% 0.89% AddedShares held: Q3 2023 173.9k, Q4 2023 107.8k, Q1 2024 98.6k, Q2 2024 101.5k +2.9k +2,937 3.0%
28 PENUMBRA INC COM PEN PEN 282,049 $50.8m0.82% 0.82% AddedShares held: Q3 2023 237.3k, Q4 2023 203.0k, Q1 2024 181.2k, Q2 2024 282.0k +100.9k +100,891 55.7%
29 EXACT SCIENCES CORP COM EXAS EXAS 1,158,880 $49.0m0.80% 0.80% AddedShares held: Q3 2023 1.1m, Q4 2023 1.0m, Q1 2024 1.1m, Q2 2024 1.2m +20.4k +20,354 1.8%
30 ZIMMER BIOMET HOLDINGS INC COM ZBH ZBH 449,081 $48.7m0.79% 0.79% AddedShares held: Q3 2023 284.9k, Q4 2023 281.1k, Q1 2024 282.2k, Q2 2024 449.1k +166.9k +166,864 59.1%
31 SAGE THERAPEUTICS INC COM SAGE SAGE 4,464,693 $48.5m0.79% 0.79% ReducedShares held: Q3 2023 3.5m, Q4 2023 3.5m, Q1 2024 4.5m, Q2 2024 4.5m -851 -851 -0.0%
32 CHARLES RIV LABS INTL INC COM CRL CRL 232,702 $48.1m0.78% 0.78% AddedShares held: Q3 2023 229.3k, Q4 2023 217.8k, Q1 2024 229.7k, Q2 2024 232.7k +3.0k +3,005 1.3%
33 IDEXX LABS INC COM IDXX IDXX 93,358 $45.5m0.74% 0.74% UnchangedShares held: Q3 2023 114.4k, Q4 2023 94.1k, Q1 2024 93.4k, Q2 2024 93.4k
34 ELI LILLY & CO COM LLY LLY 49,674 $45.0m0.73% 0.73% ReducedShares held: Q3 2023 81.5k, Q4 2023 56.2k, Q1 2024 58.0k, Q2 2024 49.7k -8.3k -8,291 -14.3%
35 BIO RAD LABS INC CL A BIO BIO 155,258 $42.4m0.69% 0.69% ReducedShares held: Q3 2023 134.3k, Q4 2023 141.1k, Q1 2024 156.6k, Q2 2024 155.3k -1.4k -1,360 -0.9%
36 MACROGENICS INC COM MGNX MGNX 9,942,313 $42.3m0.69% 0.69% ReducedShares held: Q3 2023 9.8m, Q4 2023 10.0m, Q1 2024 10.0m, Q2 2024 9.9m -23.5k -23,549 -0.2%
37 AXSOME THERAPEUTICS INC COM AXSM AXSM 516,533 $41.6m0.68% 0.68% ReducedShares held: Q3 2023 631.5k, Q4 2023 635.4k, Q1 2024 685.5k, Q2 2024 516.5k -168.9k -168,943 -24.6%
38 RELAY THERAPEUTICS INC COM RLAY RLAY 6,377,115 $41.6m0.68% 0.68% AddedShares held: Q3 2023 4.9m, Q4 2023 5.9m, Q1 2024 5.9m, Q2 2024 6.4m +450.5k +450,497 7.6%
39 ESSA PHARMA INC COM NEW EPI EPI 7,889,583 $41.5m0.67% 0.67% UnchangedShares held: Q3 2023 7.9m, Q4 2023 7.9m, Q1 2024 7.9m, Q2 2024 7.9m
40 PROCEPT BIOROBOTICS CORP COM PRCT PRCT 669,049 $40.9m0.66% 0.66% ReducedShares held: Q3 2023 888.3k, Q4 2023 885.3k, Q1 2024 890.1k, Q2 2024 669.0k -221.1k -221,065 -24.8%
41 THE CIGNA GROUP COM CI CI 123,090 $40.7m0.66% 0.66% AddedShares held: Q3 2023 125.5k, Q4 2023 88.5k, Q1 2024 79.6k, Q2 2024 123.1k +43.4k +43,445 54.5%
42 GE HEALTHCARE TECHNOLOGIES I COMMON STOCK GEHC GEHC 521,017 $40.6m0.66% 0.66% AddedShares held: Q3 2023 12.5k, Q4 2023 535.2k, Q1 2024 512.2k, Q2 2024 521.0k +8.8k +8,787 1.7%
43 EXELIXIS INC COM EXEL EXEL 1,803,200 $40.5m0.66% 0.66% ReducedShares held: Q3 2023 2.4m, Q4 2023 2.1m, Q1 2024 1.9m, Q2 2024 1.8m -100.0k -100,000 -5.2%
44 SAREPTA THERAPEUTICS INC COM SRPT SRPT 252,321 $39.9m0.65% 0.65% AddedShares held: Q3 2023 241.8k, Q4 2023 237.3k, Q1 2024 251.5k, Q2 2024 252.3k +800 +800 0.3%
45 BLACK DIAMOND THERAPEUTICS I COM BDTX BDTX 8,517,839 $39.7m0.64% 0.64% UnchangedShares held: Q3 2023 8.1m, Q4 2023 8.5m, Q1 2024 8.5m, Q2 2024 8.5m
46 HCA HEALTHCARE INC COM HCA HCA 122,304 $39.3m0.64% 0.64% ReducedShares held: Q3 2023 155.6k, Q4 2023 152.2k, Q1 2024 159.7k, Q2 2024 122.3k -37.4k -37,399 -23.4%
47 OPTION CARE HEALTH INC COM NEW OPCH OPCH 1,416,879 $39.2m0.64% 0.64% ReducedShares held: Q3 2023 2.3m, Q4 2023 1.9m, Q1 2024 1.9m, Q2 2024 1.4m -450.4k -450,384 -24.1%
48 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 1,154,654 $39.1m0.64% 0.64% AddedShares held: Q3 2023 19.9k, Q4 2023 976.1k, Q1 2024 972.3k, Q2 2024 1.2m +182.4k +182,400 18.8%
49 ALIGN TECHNOLOGY INC COM ALGN ALGN 143,982 $34.8m0.56% 0.56% ReducedShares held: Q3 2023 166.9k, Q4 2023 159.4k, Q1 2024 154.9k, Q2 2024 144.0k -10.9k -10,927 -7.0%
50 COOPER COS INC COM COO COO 397,373 $34.7m0.56% 0.56% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 397.4k, Q2 2024 397.4k
51 GLOBUS MED INC CL A GMED GMED 497,293 $34.1m0.55% 0.55% ReducedShares held: Q3 2023 609.6k, Q4 2023 607.8k, Q1 2024 579.9k, Q2 2024 497.3k -82.6k -82,605 -14.2%
52 REGENERON PHARMACEUTICALS COM REGN REGN 32,297 $33.9m0.55% 0.55% AddedShares held: Q3 2023 14.9k, Q4 2023 10.7k, Q1 2024 7.1k, Q2 2024 32.3k +25.2k +25,220 356.4%
53 CRISPR THERAPEUTICS AG NAMEN AKT CRSP CRSP 617,649 $33.4m0.54% 0.54% ReducedShares held: Q3 2023 898.4k, Q4 2023 900.4k, Q1 2024 620.0k, Q2 2024 617.6k -2.3k -2,301 -0.4%
54 BEAM THERAPEUTICS INC COM BEAM BEAM 1,418,121 $33.2m0.54% 0.54% AddedShares held: Q3 2023 694.8k, Q4 2023 694.8k, Q1 2024 1.2m, Q2 2024 1.4m +225.0k +225,000 18.9%
55 EVOLENT HEALTH INC CL A EVH EVH 1,669,835 $31.9m0.52% 0.52% AddedShares held: Q3 2023 3.7m, Q4 2023 2.4m, Q1 2024 1.5m, Q2 2024 1.7m +186.7k +186,739 12.6%
56 VEEVA SYS INC CL A COM VEEV VEEV 168,583 $30.9m0.50% 0.50% AddedShares held: Q3 2023 224.1k, Q4 2023 195.0k, Q1 2024 168.2k, Q2 2024 168.6k +336 +336 0.2%
57 TRANSMEDICS GROUP INC COM TMDX TMDX 201,415 $30.3m0.49% 0.49% ReducedShares held: Q3 2023 536.7k, Q4 2023 518.9k, Q1 2024 364.1k, Q2 2024 201.4k -162.6k -162,649 -44.7%
58 RESMED INC COM RMD RMD 155,881 $29.8m0.48% 0.48% AddedShares held: Q3 2023 76.7k, Q4 2023 30.3k, Q1 2024 30.4k, Q2 2024 155.9k +125.5k +125,490 412.9%
59 CENTENE CORP DEL COM CNC CNC 421,458 $27.9m0.45% 0.45% AddedShares held: Q3 2023 444.0k, Q4 2023 441.9k, Q1 2024 363.1k, Q2 2024 421.5k +58.4k +58,358 16.1%
60 MCKESSON CORP COM MCK MCK 46,142 $26.9m0.44% 0.44% AddedShares held: Q3 2023 5.4k, Q4 2023 4.9k, Q1 2024 9.0k, Q2 2024 46.1k +37.1k +37,145 412.9%
61 CASTLE BIOSCIENCES INC COM CSTL CSTL 1,217,101 $26.5m0.43% 0.43% ReducedShares held: Q3 2023 1.2m, Q4 2023 1.2m, Q1 2024 1.2m, Q2 2024 1.2m -3.0k -2,984 -0.2%
62 EDGEWISE THERAPEUTICS INC COM EWTX EWTX 1,428,929 $25.7m0.42% 0.42% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 1.4m
63 ANNEXON INC COM ANNX ANNX 5,157,290 $25.3m0.41% 0.41% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 2.2m, Q2 2024 5.2m +3.0m +2,975,000 136.3%
64 THERMO FISHER SCIENTIFIC INC COM TMO TMO 42,626 $23.6m0.38% 0.38% AddedShares held: Q3 2023 66.5k, Q4 2023 35.3k, Q1 2024 40.0k, Q2 2024 42.6k +2.7k +2,670 6.7%
65 NATERA INC COM NTRA NTRA 213,987 $23.2m0.38% 0.38% ReducedShares held: Q3 2023 257.7k, Q4 2023 256.6k, Q1 2024 269.8k, Q2 2024 214.0k -55.8k -55,845 -20.7%
66 SILK RD MED INC COM SILK SILK 855,293 $23.1m0.38% 0.38% ReducedShares held: Q3 2023 1.4m, Q4 2023 1.4m, Q1 2024 1.5m, Q2 2024 855.3k -662.9k -662,937 -43.7%
67 MOLINA HEALTHCARE INC COM MOH MOH 76,393 $22.7m0.37% 0.37% ReducedShares held: Q3 2023 158.4k, Q4 2023 91.5k, Q1 2024 99.9k, Q2 2024 76.4k -23.5k -23,490 -23.5%
68 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 9,944,064 $22.1m0.36% 0.36% UnchangedShares held: Q3 2023 4.2m, Q4 2023 4.2m, Q1 2024 9.9m, Q2 2024 9.9m
69 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 557,321 $21.9m0.36% 0.36% AddedShares held: Q3 2023 16.8k, Q4 2023 12.3k, Q1 2024 363.9k, Q2 2024 557.3k +193.4k +193,395 53.1%
70 DANAHER CORPORATION COM DHR DHR 83,920 $21.0m0.34% 0.34% ReducedShares held: Q3 2023 136.5k, Q4 2023 84.3k, Q1 2024 86.2k, Q2 2024 83.9k -2.3k -2,312 -2.7%
71 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 4,094,458 $20.4m0.33% 0.33% UnchangedShares held: Q3 2023 4.5m, Q4 2023 4.5m, Q1 2024 4.1m, Q2 2024 4.1m
72 CENCORA INC COM COR COR 89,329 $20.1m0.33% 0.33% ReducedShares held: Q3 2023 17.1k, Q4 2023 126.1k, Q1 2024 131.5k, Q2 2024 89.3k -42.2k -42,175 -32.1%
73 STERIS PLC SHS USD STE STE 91,282 $20.0m0.33% 0.33% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 73.4k, Q2 2024 91.3k +17.8k +17,848 24.3%
74 HUTCHMED CHINA LTD SPONSORED ADS HCM HCM 1,149,157 $19.7m0.32% 0.32% ReducedShares held: Q3 2023 1.8m, Q4 2023 1.1m, Q1 2024 1.2m, Q2 2024 1.1m -5.5k -5,475 -0.5%
75 IQVIA HLDGS INC COM IQV IQV 92,083 $19.5m0.32% 0.32% AddedShares held: Q3 2023 155.2k, Q4 2023 8.3k, Q1 2024 8.3k, Q2 2024 92.1k +83.7k +83,747 1004.6%
76 PRIVIA HEALTH GROUP INC COM PRVA PRVA 1,059,171 $18.4m0.30% 0.30% UnchangedShares held: Q3 2023 1.1m, Q4 2023 1.1m, Q1 2024 1.1m, Q2 2024 1.1m
77 HOLOGIC INC COM HOLX HOLX 247,826 $18.4m0.30% 0.30% ReducedShares held: Q3 2023 290.1k, Q4 2023 289.9k, Q1 2024 290.0k, Q2 2024 247.8k -42.1k -42,143 -14.5%
78 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 2,165,203 $18.0m0.29% 0.29% UnchangedShares held: Q3 2023 2.1m, Q4 2023 2.2m, Q1 2024 2.2m, Q2 2024 2.2m
79 SI-BONE INC COM SIBN SIBN 1,387,609 $17.9m0.29% 0.29% AddedShares held: Q3 2023 0, Q4 2023 125.2k, Q1 2024 1.1m, Q2 2024 1.4m +247.7k +247,653 21.7%
80 APELLIS PHARMACEUTICALS INC COM APLS APLS 444,404 $17.0m0.28% 0.28% ReducedShares held: Q3 2023 793.8k, Q4 2023 821.8k, Q1 2024 473.9k, Q2 2024 444.4k -29.5k -29,511 -6.2%
81 INSPIRE MED SYS INC COM INSP INSP 124,724 $16.7m0.27% 0.27% ReducedShares held: Q3 2023 70.4k, Q4 2023 215.6k, Q1 2024 217.7k, Q2 2024 124.7k -93.0k -92,970 -42.7%
82 NEOGENOMICS INC COM NEW NEO NEO 1,202,096 $16.7m0.27% 0.27% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 946.0k, Q2 2024 1.2m +256.1k +256,071 27.1%
83 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 1,134,229 $16.4m0.27% 0.27% ReducedShares held: Q3 2023 856.4k, Q4 2023 840.0k, Q1 2024 1.1m, Q2 2024 1.1m -5.1k -5,066 -0.4%
84 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 369,270 $16.4m0.27% 0.27% AddedShares held: Q3 2023 278.2k, Q4 2023 201.8k, Q1 2024 293.3k, Q2 2024 369.3k +76.0k +76,000 25.9%
85 FATE THERAPEUTICS INC COM FATE FATE 4,839,779 $15.9m0.26% 0.26% UnchangedShares held: Q3 2023 4.9m, Q4 2023 4.9m, Q1 2024 4.8m, Q2 2024 4.8m
86 GENERATION BIO CO COM COM 3,918,856 $11.1m0.18% 0.18% AddedShares held: Q3 2023 3.6m, Q4 2023 3.6m, Q1 2024 3.9m, Q2 2024 3.9m +57.3k +57,281 1.5%
87 HUMANA INC COM HUM HUM 28,440 $10.6m0.17% 0.17% ReducedShares held: Q3 2023 170.0k, Q4 2023 100.5k, Q1 2024 135.5k, Q2 2024 28.4k -107.1k -107,101 -79.0%
88 ASTRANA HEALTH INC COM NEW ASTH ASTH 250,617 $10.2m0.17% 0.17% AddedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 10.3k, Q2 2024 250.6k +240.4k +240,361 2343.6%
89 PHREESIA INC COM PHR PHR 443,341 $9.4m0.15% 0.15% UnchangedShares held: Q3 2023 579.0k, Q4 2023 421.6k, Q1 2024 443.3k, Q2 2024 443.3k
90 MERCK & CO INC COM MRK MRK 74,709 $9.2m0.15% 0.15% ReducedShares held: Q3 2023 291.9k, Q4 2023 290.2k, Q1 2024 310.9k, Q2 2024 74.7k -236.1k -236,142 -76.0%
91 AMGEN INC COM AMGN AMGN 29,528 $9.2m0.15% 0.15% AddedShares held: Q3 2023 48.5k, Q4 2023 34.2k, Q1 2024 22.1k, Q2 2024 29.5k +7.4k +7,389 33.4%
92 ABBVIE INC COM ABBV ABBV 42,204 $7.2m0.12% 0.12% AddedShares held: Q3 2023 4.8k, Q4 2023 6.7k, Q1 2024 27.6k, Q2 2024 42.2k +14.6k +14,611 53.0%
93 GLAUKOS CORP COM GKOS GKOS 55,926 $6.6m0.11% 0.11% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 55.9k, Q2 2024 55.9k
94 OMNICELL COM COM OMCL OMCL 235,372 $6.4m0.10% 0.10% UnchangedShares held: Q3 2023 239.3k, Q4 2023 223.8k, Q1 2024 235.4k, Q2 2024 235.4k
95 10X GENOMICS INC CL A COM TXG TXG 308,311 $6.0m0.10% 0.10% UnchangedShares held: Q3 2023 294.4k, Q4 2023 293.2k, Q1 2024 308.3k, Q2 2024 308.3k
96 ATRICURE INC COM ATRC ATRC 212,559 $4.8m0.08% 0.08% ReducedShares held: Q3 2023 747.6k, Q4 2023 817.9k, Q1 2024 447.4k, Q2 2024 212.6k -234.8k -234,817 -52.5%
97 ILLUMINA INC COM ILMN ILMN 43,596 $4.6m0.07% 0.07% UnchangedShares held: Q3 2023 72.0k, Q4 2023 45.0k, Q1 2024 43.6k, Q2 2024 43.6k
98 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 52,232 $4.3m0.07% 0.07% ReducedShares held: Q3 2023 349.9k, Q4 2023 325.8k, Q1 2024 321.8k, Q2 2024 52.2k -269.6k -269,555 -83.8%
99 ALTIMMUNE INC COM NEW ALT ALT 600,000 $4.0m0.06% 0.06% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 600.0k
100 BEIGENE LTD SPONSORED ADR ONC ONC 25,629 $3.7m0.06% 0.06% AddedShares held: Q3 2023 53.2k, Q4 2023 28.6k, Q1 2024 24.9k, Q2 2024 25.6k +700 +700 2.8%

Sold out since Q1 2024

SecurityTickerShares held beforeValue then
SHOCKWAVE MED INC SWAV SWAV 105,786 $34.4m105.8k shares
PACIFIC BIOSCIENCES CALIF IN PACB PACB 4,592,251 $17.2m4.6m shares
SPDR S&P 500 ETF TR SPY SPY 6,660 $3.5m6.7k shares
BRISTOL-MYERS SQUIBB CO BMY BMY 23,436 $1.3m23.4k shares
VANECK ETF TRUST GDX GDX 33,000 $1.0m33.0k shares
VERVE THERAPEUTICS INC 29,200 $387.8k29.2k shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 19,100 $334.4k19.1k shares
SIMPLY GOOD FOODS CO SMPL SMPL 7,900 $268.8k7.9k shares
BIOMEA FUSION INC BMEA BMEA 17,800 $266.1k17.8k shares
REGENXBIO INC RGNX RGNX 12,000 $252.8k12.0k shares
BAXTER INTL INC BAX BAX 4,200 $179.5k4.2k shares
LABORATORY CORP AMER HLDGS 148 $32.3k148 shares
IONQ INC IONQ IONQ 1,107 $11.1k1.1k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
VIRIDIAN THERAPEUTICS INC VRDN · 13G · filed 2026-05-15 VRDN 6.6%≈ $123.6m new 13G 2026-05-15
IMMUNOCORE HLDGS PLC IMCR · 13G · filed 2025-11-14 IMCR 5.6% new 13G 2025-11-14
JADE BIOSCIENCES INC JBIO · 13G · filed 2026-08-14 JBIO 5.0%≈ $67.9m -1.8 pts 13G 2026-08-14